Wells Fargo & Company MN Sells 28,693 Shares of National Research Co. (NASDAQ:NRC)

Wells Fargo & Company MN lowered its position in shares of National Research Co. (NASDAQ:NRC - Free Report) by 16.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 143,145 shares of the company's stock after selling 28,693 shares during the period. Wells Fargo & Company MN owned about 0.61% of National Research worth $2,525,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. State Street Corp raised its holdings in National Research by 4.0% in the 3rd quarter. State Street Corp now owns 363,438 shares of the company's stock worth $8,351,000 after purchasing an additional 14,144 shares in the last quarter. Barclays PLC raised its stake in National Research by 65.6% in the third quarter. Barclays PLC now owns 51,331 shares of the company's stock worth $1,175,000 after buying an additional 20,331 shares in the last quarter. Geode Capital Management LLC lifted its holdings in National Research by 3.2% in the third quarter. Geode Capital Management LLC now owns 420,733 shares of the company's stock worth $9,619,000 after buying an additional 13,039 shares during the period. Principal Financial Group Inc. bought a new stake in National Research during the 3rd quarter valued at approximately $248,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of National Research by 8.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 17,194 shares of the company's stock worth $393,000 after acquiring an additional 1,373 shares during the period. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Stock Up 6.6 %

Shares of NRC traded up $0.72 on Tuesday, reaching $11.56. The stock had a trading volume of 81,703 shares, compared to its average volume of 87,422. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. National Research Co. has a 12-month low of $9.76 and a 12-month high of $35.81. The firm has a market capitalization of $265.26 million, a price-to-earnings ratio of 11.01 and a beta of 0.41. The company has a 50-day simple moving average of $13.21 and a 200-day simple moving average of $16.47.

National Research (NASDAQ:NRC - Get Free Report) last announced its earnings results on Monday, April 28th. The company reported $0.25 EPS for the quarter. The firm had revenue of $33.55 million for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.15%. The ex-dividend date of this dividend was Friday, March 28th. National Research's dividend payout ratio is 45.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.